Uncategorized - malecare.org

Morbidity and Treatment Regret in Men with Advanced Prostate Cancer

The question of today’s post is do men with advanced prostate cancer develop treatment regrets concurrent to their development of morbidity issues ( i.e.- myocardial infarction, congestive heart failure, angina, diabetes, stroke, circulation problems, inflammatory bowel disease, or amputation)? To answer this question researchers evaluated 795 men from the Comprehensive, Observational, Multicenter, Prostate Adenocarcinoma Registry [...]

By Malecare|2011-09-08T14:02:36-04:00September 8th, 2011|Advanced Prostate Cancer, General Information, How We Live, Research, Uncategorized, Understanding APC|1 Comment

The White House Declares September as National Prostate Cancer Awareness Month

The White House Office of the Press Secretary For Immediate Release September 01, 2011 Presidential Proclamation — National Prostate Cancer Awareness Month […]

By Malecare|2011-09-06T19:43:09-04:00September 6th, 2011|Advanced Prostate Cancer, General Information, Politics of Cancer, Uncategorized|2 Comments

New Data on Long-Term Use of Firmagon® (degarelix) For Men with Advanced Hormone Dependant Prostate Cancer

New data, published September 1 in the Journal of Urology, shows that Firmagon® (degarelix) which is a gonadotropin-releasing hormone therapy (GnRH) given to men with advanced prostate cancer may be superior to leuprolide when used over three years. This new study (CS21A) was an open-label extension of the Phase III study (CS21) in which Firmagon® [...]

By Malecare|2011-09-04T12:51:17-04:00September 4th, 2011|Advanced Prostate Cancer, Drugs & Treatments, Firmagon (degarelix), Uncategorized, Understanding APC|0 Comments

Light A Blue Light Bulb for Prostate Cancer Awareness Month – September

Light a Blue Bulb for Prostate Cancer Awareness Month, September 2011. This year, let’s take prostate cancer awareness building into our own hands. Light a Blue Bulb every night (or, for a few nights) during September. […]

By Malecare|2017-10-19T10:52:05-04:00August 26th, 2011|Advanced Prostate Cancer, Advocacy, Inspiration, Politics of Cancer, Uncategorized|1 Comment

Cabozantinib, Promising, Still Controversial For the Treatment of Bone Mets in Prostate Cancer

Cabozantinib (cabo), has many of us prostate cancer survivor, educators and researchers simply scratching their heads. In trials, Cabozantinib demonstrated what some people have characterized as mind boggling activity against bone metastases. In trials the drug led to partial or complete resolution of bone scans in a substantial portion of patients with cancer, including prostate, [...]

By Malecare|2017-10-19T10:52:06-04:00August 24th, 2011|Advanced Prostate Cancer, Alpharadin (radium-223), cabozantinib, Drugs & Treatments, General Information, Imaging, Metastases, Research, Uncategorized, Understanding APC|3 Comments